Integrated UPLC/Q-TOF-MS/MS Analysis and Network Pharmacology to Reveal the Neuroprotective Mechanisms and Potential Pharmacological Ingredients of Aurantii Fructus Immaturus and Aurantii Fructus.

Authors:
Qiu M; Zhang J; Wei W; Zhang Y; Li M and 4 more

Journal:
Pharmaceuticals (Basel)

Publication Year: 2024

DOI:
10.3390/ph17020239

PMCID:
PMC10892462

PMID:
38399454

Journal Information

Full Title: Pharmaceuticals (Basel)

Abbreviation: Pharmaceuticals (Basel)

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest The authors declare that they have no competing financial interests associated with this work."

Evidence found in paper:

"This research was funded by Shanghai Sailing Program (No. 21YF1455800), National Natural Science Foundation of China (No. 82003940; No. 82003938; No. 82104385), Qi-Huang Chief Scientist Project of National Administration of Traditional Chinese Medicine (2020), Sanming Project of Medicine in Shenzhen (No. SZZYSM202106004), Key Program of National Natural Science Foundation of China (No. 82130111) and Key-Area Research and Development Program of Guangdong Province (No. 2020B1111110007)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025